glp 1 new drug Eli Lilly to seek approval of GLP-1 weight-loss this year GLP-1 Weight Loss Drugs May
Description
Mol Ther Nucleic Acids (2020) 23:61428
:max_bytes(150000):strip_icc():focal(749x0:751x2)/gpl-1-jabs-052226-1-010a064224da4f85bf4c6ea0952739c8.jpg)
Simply put, while a severe calorie deficit may prove to be temporarily effective for weight loss, it is not an ideal solution

NNC0165-1875 has recently completed a phase 2 trial in combination with semaglutide 2.4 mg once weekly (NCT04969939), but results are not currently available
A., Deshmukh, H., Atkin, S., & Sathyapalan, T

processed cryo-EM data, modeled, refined and analyzed the structure, wrote manuscript with input from all authors
